Jake Bauer's most recent trade in Enliven Therapeutics Inc was a trade of 23,364 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enliven Therapeutics Inc | Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 87,372 | 87,372 | - | - | Common Stock | |
| Enliven Therapeutics Inc | Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 17,706 | 17,706 | - | - | Stock Option |